Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> GILEAD SCIENCES Latest News

MAY 20, 2015 - TheStreet

A Must Read - Share

10 S&P 500 Companies to Have the Most Revenue Growth in 2015

NEW YORK (TheStreet) -- Which S&P 500 companies are poised to have the biggest revenue growth this year? With first-quarter earnings reports just about wrapped up after several big retail chains issued results this week, S&P Capital IQ, a division of McGraw Hill Financial , analyzed revenue estimates for companies with market capitalization of at least $20 billion to identify those ...

Tags: 10 S&P 500 Companies to Have the Most Revenue Growth in 2015,  Gilead Sciences Latest News

MAY 20, 2015 - TheStreet

A Must Read - Share

10 S&P 500 Companies to Have the Biggest Profit Growth in 2015

NEW YORK (TheStreet) -- Which S&P 500 companies are poised to have the biggest profit growth rates this year? With first-quarter earnings reports wrapping up with results from retailers this week, S&P Capital IQ, a division of McGraw Hill Financial , analyzed annual earnings-per-share estimates for S&P 500 companies with a market capitalization of at least $20 billion to identify those ...

Tags: 10 S&P 500 Companies to Have the Biggest Profit Growth in 2015,  Gilead Sciences Latest News

MAY 19, 2015 - TheStreet

A Must Read - Share

3 Best Biotech Stocks to Add to Your Portfolio

NEW YORK (TheStreet) -- Biotech, driven by the demand for effective treatments and new cures, is one of the hottest investment areas today. There has even been speculation of a biotech bubble and speculation can often drive stock movement. The sector has been growing at an annual rate of 9% since 1997, well above the overall economy.  The U.S. dominates the ...

Tags: 3 Best Biotech Stocks to Add to Your Portfolio,  Gilead Sciences Latest News

MAY 19, 2015 - TheStreet

A Must Read - Share

Gilead Sciences Buying Achillion Was Twitter Speculation at its Finest

BOSTON (TheStreet) -- For a brief moment, and mostly on Twitter, Gilead Sciences was buying Achillion Pharmaceuticals . The speculation of another hepatitis C-related acquisition took off Monday afternoon, sparked by a rumor that Gilead executives canceled a scheduled Tuesday presentation at a healthcare investor conference. Earlier Monday, Achillion Pharmaceuticals cancelled its presentation at the same investor conference. You see where ...

Tags: Gilead Sciences Buying Achillion Was Twitter Speculation at its Finest,  Gilead Sciences Latest News

MAY 18, 2015 - Benzinga

A Must Read - Share

Top Street Analysts Like Gilead Sciences

Gilead Sciences, Inc. (NASDAQ: GILD) has been a favorite among biotech investors due to its successful hepatitis C therapies; Harvoni and Sovaldi. However, the biopharmaceutical company is making headlines again with a new drug for gastric cancer; GS-5745. Latest Ratings for GILD DateFirmActionFromTo Apr 2015OppenheimerAssumesOutperform Feb 2015Credit SuisseDowngradesOutperformNeutral Feb 2015CitigroupMaintainsBuy View More Analyst Ratings for GILD View the Latest Analyst ...

Tags: Top Street Analysts Like Gilead Sciences,  Gilead Sciences Latest News